Cargando…
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
Resistance to temozolomide (TMZ) is a major clinical challenge in glioma treatment, but the mechanisms of TMZ resistance are poorly understood. Here, we provided evidence that ROCK2 acted redundantly to maintain resistance of TMZ in TMZ-resistant gliomas, and as a ROCK2 phosphorylation inhibitor, fa...
Autores principales: | Zhang, Xin, Liu, Xiuting, Zhou, Wei, Yang, Mengdi, Ding, Yang, Wang, Qing, Hu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833824/ https://www.ncbi.nlm.nih.gov/pubmed/29416017 http://dx.doi.org/10.1038/s41419-017-0251-9 |
Ejemplares similares
-
Acquired temozolomide resistance in MGMT(low) gliomas is associated with regulation of homologous recombination repair by ROCK2
por: Zhang, Xin, et al.
Publicado: (2022) -
Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells
por: Wen, Xiaojun, et al.
Publicado: (2014) -
Correction: Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells
Publicado: (2014) -
Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010) -
Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)